Inspire Medical Systems Inc - Asset Resilience Ratio

Latest as of December 2025: 22.15%

Inspire Medical Systems Inc (INSP) has an Asset Resilience Ratio of 22.15% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Inspire Medical Systems Inc debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

$203.46 Million
Cash + Short-term Investments

Total Assets

$918.49 Million
All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Inspire Medical Systems Inc's Asset Resilience Ratio has changed over time. See what is Inspire Medical Systems Inc's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Inspire Medical Systems Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see INSP stock market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $203.46 Million 22.15%
Total Liquid Assets $203.46 Million 22.15%

Asset Resilience Insights

  • Good Liquidity Position: Inspire Medical Systems Inc maintains a healthy 22.15% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Inspire Medical Systems Inc Industry Peers by Asset Resilience Ratio

Compare Inspire Medical Systems Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 36.63%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
Shanghai Kinetic Medical Co
SHE:300326
Medical Devices 28.89%
Eurobio Scientific SA
PA:ALERS
Medical Devices 10.52%
EBR Systems Inc
AU:EBR
Medical Devices 48.75%
Aroa Biosurgery Ltd
AU:ARX
Medical Devices 12.13%
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
Medical Devices 19.31%
Affluent Medical SAS
PA:AFME
Medical Devices 0.03%

Annual Asset Resilience Ratio for Inspire Medical Systems Inc (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Inspire Medical Systems Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 22.42% $203.46 Million $907.32 Million -14.12pp
2024-12-31 36.54% $295.40 Million $808.38 Million -4.07pp
2023-12-31 40.61% $274.84 Million $676.81 Million +38.87pp
2022-12-31 1.74% $9.82 Million $564.88 Million --
2021-12-31 0.00% $0.00 $295.08 Million --
2020-12-31 15.59% $43.84 Million $281.19 Million -54.26pp
2019-12-31 69.85% $126.61 Million $181.25 Million +24.41pp
2018-12-31 45.44% $90.92 Million $200.08 Million +16.80pp
2017-12-31 28.65% $7.19 Million $25.09 Million --
2016-12-31 0.00% $0.00 $13.12 Million --
pp = percentage points

About Inspire Medical Systems Inc

NYSE:INSP USA Medical Devices
Market Cap
$1.31 Billion
Market Cap Rank
#8007 Global
#2214 in USA
Share Price
$45.70
Change (1 day)
-5.28%
52-Week Range
$45.70 - $159.76
All Time High
$326.08
About

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develop… Read more